nodes	percent_of_prediction	percent_of_DWPC	metapath
Sparfloxacin—ABCB1—kidney cancer	0.242	1	CbGaD
Sparfloxacin—SLC22A5—Dactinomycin—kidney cancer	0.08	0.147	CbGbCtD
Sparfloxacin—TOP2A—Doxorubicin—kidney cancer	0.0584	0.108	CbGbCtD
Sparfloxacin—ABCC2—Paclitaxel—kidney cancer	0.0445	0.0818	CbGbCtD
Sparfloxacin—ABCB1—Temsirolimus—kidney cancer	0.0422	0.0778	CbGbCtD
Sparfloxacin—ABCC2—Sorafenib—kidney cancer	0.0395	0.0727	CbGbCtD
Sparfloxacin—ABCC2—Vinblastine—kidney cancer	0.039	0.0718	CbGbCtD
Sparfloxacin—ABCC2—Vincristine—kidney cancer	0.0383	0.0706	CbGbCtD
Sparfloxacin—ABCC2—Sunitinib—kidney cancer	0.032	0.0589	CbGbCtD
Sparfloxacin—ABCC2—Doxorubicin—kidney cancer	0.024	0.0441	CbGbCtD
Sparfloxacin—ABCB1—Pazopanib—kidney cancer	0.0222	0.0408	CbGbCtD
Sparfloxacin—ABCB1—Dactinomycin—kidney cancer	0.0203	0.0374	CbGbCtD
Sparfloxacin—ABCB1—Gemcitabine—kidney cancer	0.016	0.0295	CbGbCtD
Sparfloxacin—ABCB1—Erlotinib—kidney cancer	0.0158	0.0291	CbGbCtD
Sparfloxacin—ABCB1—Paclitaxel—kidney cancer	0.0145	0.0267	CbGbCtD
Sparfloxacin—ABCB1—Sorafenib—kidney cancer	0.0129	0.0237	CbGbCtD
Sparfloxacin—ABCB1—Vinblastine—kidney cancer	0.0127	0.0234	CbGbCtD
Sparfloxacin—ABCB1—Vincristine—kidney cancer	0.0125	0.023	CbGbCtD
Sparfloxacin—ABCB1—Sunitinib—kidney cancer	0.0104	0.0192	CbGbCtD
Sparfloxacin—ABCB1—Doxorubicin—kidney cancer	0.00781	0.0144	CbGbCtD
Sparfloxacin—SLC22A5—Temsirolimus—Everolimus—kidney cancer	0.00137	0.296	CbGdCrCtD
Sparfloxacin—TOP2A—Gastric Cancer Network 1—TPX2—kidney cancer	0.000946	0.0898	CbGpPWpGaD
Sparfloxacin—TOP2A—Docetaxel—Paclitaxel—kidney cancer	0.000737	0.16	CbGdCrCtD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—HLTF—kidney cancer	0.000609	0.0579	CbGpPWpGaD
Sparfloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—FOSL2—kidney cancer	0.000573	0.0544	CbGpPWpGaD
Sparfloxacin—ABCC2—Codeine and Morphine Metabolism—ABCB1—kidney cancer	0.000461	0.0438	CbGpPWpGaD
Sparfloxacin—ABCC2—Irinotecan Pathway—BCHE—kidney cancer	0.000391	0.0372	CbGpPWpGaD
Sparfloxacin—TOP2A—Vindesine—Vincristine—kidney cancer	0.000375	0.0812	CbGdCrCtD
Sparfloxacin—TOP2A—Vindesine—Vinblastine—kidney cancer	0.000375	0.0812	CbGdCrCtD
Sparfloxacin—TOP2A—Gefitinib—Erlotinib—kidney cancer	0.000353	0.0765	CbGdCrCtD
Sparfloxacin—TOP2A—Gastric Cancer Network 1—AURKA—kidney cancer	0.00032	0.0304	CbGpPWpGaD
Sparfloxacin—ABCC2—Drug Induction of Bile Acid Pathway—ABCB1—kidney cancer	0.000252	0.024	CbGpPWpGaD
Sparfloxacin—TOP2A—Vinorelbine—Vinblastine—kidney cancer	0.000237	0.0513	CbGdCrCtD
Sparfloxacin—TOP2A—Vinorelbine—Vincristine—kidney cancer	0.000237	0.0513	CbGdCrCtD
Sparfloxacin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—kidney cancer	0.000213	0.0202	CbGpPWpGaD
Sparfloxacin—ABCC2—Irinotecan Pathway—APC—kidney cancer	0.000212	0.0202	CbGpPWpGaD
Sparfloxacin—TOP2A—Vincristine—Vinblastine—kidney cancer	0.000202	0.0438	CbGdCrCtD
Sparfloxacin—TOP2A—Gastric Cancer Network 1—APC—kidney cancer	0.000169	0.0161	CbGpPWpGaD
Sparfloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—kidney cancer	0.000165	0.0157	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—HARS—kidney cancer	0.000164	0.0156	CbGpPWpGaD
Sparfloxacin—TOP2A—Vinblastine—Vincristine—kidney cancer	0.000163	0.0353	CbGdCrCtD
Sparfloxacin—ABCC2—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	0.000152	0.0144	CbGpPWpGaD
Sparfloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	0.000145	0.0138	CbGpPWpGaD
Sparfloxacin—ABCC2—ABC-family proteins mediated transport—ABCB1—kidney cancer	0.000138	0.0131	CbGpPWpGaD
Sparfloxacin—TOP2A—Cytarabine—Gemcitabine—kidney cancer	0.000133	0.0288	CbGdCrCtD
Sparfloxacin—TOP2A—Daunorubicin—Doxorubicin—kidney cancer	0.000114	0.0247	CbGdCrCtD
Sparfloxacin—TOP2A—Epirubicin—Doxorubicin—kidney cancer	0.000114	0.0247	CbGdCrCtD
Sparfloxacin—TOP2A—Idarubicin—Doxorubicin—kidney cancer	0.000114	0.0247	CbGdCrCtD
Sparfloxacin—ABCC2—NRF2 pathway—SLC5A3—kidney cancer	0.000112	0.0107	CbGpPWpGaD
Sparfloxacin—TOP2A—Gastric Cancer Network 2—CTNNB1—kidney cancer	0.000109	0.0104	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—SYNE2—kidney cancer	0.000107	0.0101	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—HNF1B—kidney cancer	0.000106	0.01	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—KCNMA1—kidney cancer	0.000103	0.00977	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—PGK1—kidney cancer	9.96e-05	0.00946	CbGpPWpGaD
Sparfloxacin—ABCC2—NRF2 pathway—KEAP1—kidney cancer	9.82e-05	0.00932	CbGpPWpGaD
Sparfloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	9.68e-05	0.00919	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—PSMD7—kidney cancer	9.62e-05	0.00913	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUND—kidney cancer	9.61e-05	0.00913	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APAF1—kidney cancer	9.61e-05	0.00913	CbGpPWpGaD
Sparfloxacin—TOP2A—Azacitidine—Gemcitabine—kidney cancer	9.53e-05	0.0207	CbGdCrCtD
Sparfloxacin—ABCB1—Allograft Rejection—LRRK2—kidney cancer	9.44e-05	0.00896	CbGpPWpGaD
Sparfloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—kidney cancer	9.35e-05	0.00888	CbGpPWpGaD
Sparfloxacin—Abdominal pain—Dactinomycin—kidney cancer	9.27e-05	0.000464	CcSEcCtD
Sparfloxacin—Body temperature increased—Dactinomycin—kidney cancer	9.27e-05	0.000464	CcSEcCtD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—NDRG1—kidney cancer	9.26e-05	0.0088	CbGpPWpGaD
Sparfloxacin—Anaphylactoid reaction—Doxorubicin—kidney cancer	9.25e-05	0.000463	CcSEcCtD
Sparfloxacin—Asthenia—Sorafenib—kidney cancer	9.23e-05	0.000462	CcSEcCtD
Sparfloxacin—TOP2A—Circadian rythm related genes—JUND—kidney cancer	9.23e-05	0.00876	CbGpPWpGaD
Sparfloxacin—Malaise—Paclitaxel—kidney cancer	9.19e-05	0.00046	CcSEcCtD
Sparfloxacin—Vertigo—Paclitaxel—kidney cancer	9.16e-05	0.000459	CcSEcCtD
Sparfloxacin—Hypersensitivity—Sunitinib—kidney cancer	9.12e-05	0.000457	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	9.11e-05	0.00865	CbGpPWpGaD
Sparfloxacin—Decreased appetite—Vincristine—kidney cancer	9.11e-05	0.000456	CcSEcCtD
Sparfloxacin—Pruritus—Sorafenib—kidney cancer	9.11e-05	0.000456	CcSEcCtD
Sparfloxacin—Vomiting—Erlotinib—kidney cancer	9.1e-05	0.000455	CcSEcCtD
Sparfloxacin—Erythema multiforme—Capecitabine—kidney cancer	9.09e-05	0.000455	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Gemcitabine—kidney cancer	9.05e-05	0.000453	CcSEcCtD
Sparfloxacin—Rash—Erlotinib—kidney cancer	9.02e-05	0.000452	CcSEcCtD
Sparfloxacin—Dermatitis—Erlotinib—kidney cancer	9.01e-05	0.000451	CcSEcCtD
Sparfloxacin—Palpitations—Paclitaxel—kidney cancer	9.01e-05	0.000451	CcSEcCtD
Sparfloxacin—Insomnia—Gemcitabine—kidney cancer	8.99e-05	0.00045	CcSEcCtD
Sparfloxacin—Headache—Erlotinib—kidney cancer	8.96e-05	0.000449	CcSEcCtD
Sparfloxacin—Tinnitus—Capecitabine—kidney cancer	8.96e-05	0.000449	CcSEcCtD
Sparfloxacin—Constipation—Vincristine—kidney cancer	8.96e-05	0.000449	CcSEcCtD
Sparfloxacin—Pain—Vincristine—kidney cancer	8.96e-05	0.000449	CcSEcCtD
Sparfloxacin—Diplopia—Doxorubicin—kidney cancer	8.95e-05	0.000448	CcSEcCtD
Sparfloxacin—Osteoarthritis—Doxorubicin—kidney cancer	8.95e-05	0.000448	CcSEcCtD
Sparfloxacin—Paraesthesia—Gemcitabine—kidney cancer	8.92e-05	0.000447	CcSEcCtD
Sparfloxacin—Cough—Paclitaxel—kidney cancer	8.9e-05	0.000445	CcSEcCtD
Sparfloxacin—Asthenia—Sunitinib—kidney cancer	8.89e-05	0.000445	CcSEcCtD
Sparfloxacin—Dyspnoea—Gemcitabine—kidney cancer	8.86e-05	0.000444	CcSEcCtD
Sparfloxacin—Nausea—Vinblastine—kidney cancer	8.84e-05	0.000443	CcSEcCtD
Sparfloxacin—TOP2A—Gastric Cancer Network 2—MYC—kidney cancer	8.84e-05	0.00839	CbGpPWpGaD
Sparfloxacin—Somnolence—Gemcitabine—kidney cancer	8.83e-05	0.000442	CcSEcCtD
Sparfloxacin—Convulsion—Paclitaxel—kidney cancer	8.83e-05	0.000442	CcSEcCtD
Sparfloxacin—Affect lability—Doxorubicin—kidney cancer	8.81e-05	0.000441	CcSEcCtD
Sparfloxacin—Migraine—Doxorubicin—kidney cancer	8.81e-05	0.000441	CcSEcCtD
Sparfloxacin—Nausea—Everolimus—kidney cancer	8.81e-05	0.000441	CcSEcCtD
Sparfloxacin—Diarrhoea—Sorafenib—kidney cancer	8.81e-05	0.000441	CcSEcCtD
Sparfloxacin—Hypertension—Paclitaxel—kidney cancer	8.8e-05	0.000441	CcSEcCtD
Sparfloxacin—Pruritus—Sunitinib—kidney cancer	8.76e-05	0.000439	CcSEcCtD
Sparfloxacin—Myalgia—Paclitaxel—kidney cancer	8.68e-05	0.000435	CcSEcCtD
Sparfloxacin—Arthralgia—Paclitaxel—kidney cancer	8.68e-05	0.000435	CcSEcCtD
Sparfloxacin—Chest pain—Paclitaxel—kidney cancer	8.68e-05	0.000435	CcSEcCtD
Sparfloxacin—Anxiety—Paclitaxel—kidney cancer	8.65e-05	0.000433	CcSEcCtD
Sparfloxacin—Face oedema—Doxorubicin—kidney cancer	8.65e-05	0.000433	CcSEcCtD
Sparfloxacin—Decreased appetite—Gemcitabine—kidney cancer	8.64e-05	0.000433	CcSEcCtD
Sparfloxacin—Hypersensitivity—Dactinomycin—kidney cancer	8.64e-05	0.000433	CcSEcCtD
Sparfloxacin—Chills—Capecitabine—kidney cancer	8.62e-05	0.000432	CcSEcCtD
Sparfloxacin—Arrhythmia—Capecitabine—kidney cancer	8.59e-05	0.00043	CcSEcCtD
Sparfloxacin—Discomfort—Paclitaxel—kidney cancer	8.58e-05	0.000429	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Vincristine—kidney cancer	8.57e-05	0.000429	CcSEcCtD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—RYR1—kidney cancer	8.56e-05	0.00813	CbGpPWpGaD
Sparfloxacin—Dizziness—Sorafenib—kidney cancer	8.51e-05	0.000426	CcSEcCtD
Sparfloxacin—Constipation—Gemcitabine—kidney cancer	8.5e-05	0.000426	CcSEcCtD
Sparfloxacin—Pain—Gemcitabine—kidney cancer	8.5e-05	0.000426	CcSEcCtD
Sparfloxacin—Nausea—Erlotinib—kidney cancer	8.5e-05	0.000426	CcSEcCtD
Sparfloxacin—Alopecia—Capecitabine—kidney cancer	8.49e-05	0.000425	CcSEcCtD
Sparfloxacin—Dry mouth—Paclitaxel—kidney cancer	8.49e-05	0.000425	CcSEcCtD
Sparfloxacin—Mood swings—Doxorubicin—kidney cancer	8.48e-05	0.000425	CcSEcCtD
Sparfloxacin—Diarrhoea—Sunitinib—kidney cancer	8.47e-05	0.000424	CcSEcCtD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—CA9—kidney cancer	8.47e-05	0.00805	CbGpPWpGaD
Sparfloxacin—Ataxia—Doxorubicin—kidney cancer	8.42e-05	0.000422	CcSEcCtD
Sparfloxacin—Asthenia—Dactinomycin—kidney cancer	8.41e-05	0.000421	CcSEcCtD
Sparfloxacin—Confusional state—Paclitaxel—kidney cancer	8.39e-05	0.00042	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Paclitaxel—kidney cancer	8.32e-05	0.000417	CcSEcCtD
Sparfloxacin—Abdominal pain—Vincristine—kidney cancer	8.28e-05	0.000415	CcSEcCtD
Sparfloxacin—Body temperature increased—Vincristine—kidney cancer	8.28e-05	0.000415	CcSEcCtD
Sparfloxacin—Flatulence—Capecitabine—kidney cancer	8.24e-05	0.000413	CcSEcCtD
Sparfloxacin—Dry skin—Doxorubicin—kidney cancer	8.21e-05	0.000411	CcSEcCtD
Sparfloxacin—Dysgeusia—Capecitabine—kidney cancer	8.19e-05	0.00041	CcSEcCtD
Sparfloxacin—Dizziness—Sunitinib—kidney cancer	8.19e-05	0.00041	CcSEcCtD
Sparfloxacin—Feeling abnormal—Gemcitabine—kidney cancer	8.19e-05	0.00041	CcSEcCtD
Sparfloxacin—Vomiting—Sorafenib—kidney cancer	8.18e-05	0.00041	CcSEcCtD
Sparfloxacin—Abdominal pain upper—Doxorubicin—kidney cancer	8.18e-05	0.00041	CcSEcCtD
Sparfloxacin—Orthostatic hypotension—Doxorubicin—kidney cancer	8.18e-05	0.00041	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Paclitaxel—kidney cancer	8.15e-05	0.000408	CcSEcCtD
Sparfloxacin—Tachycardia—Paclitaxel—kidney cancer	8.12e-05	0.000407	CcSEcCtD
Sparfloxacin—Rash—Sorafenib—kidney cancer	8.12e-05	0.000406	CcSEcCtD
Sparfloxacin—Dermatitis—Sorafenib—kidney cancer	8.11e-05	0.000406	CcSEcCtD
Sparfloxacin—Back pain—Capecitabine—kidney cancer	8.09e-05	0.000405	CcSEcCtD
Sparfloxacin—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	8.06e-05	0.000404	CcSEcCtD
Sparfloxacin—Headache—Sorafenib—kidney cancer	8.06e-05	0.000404	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Paclitaxel—kidney cancer	8.04e-05	0.000403	CcSEcCtD
Sparfloxacin—Diarrhoea—Dactinomycin—kidney cancer	8.02e-05	0.000402	CcSEcCtD
Sparfloxacin—Anorexia—Paclitaxel—kidney cancer	7.93e-05	0.000397	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	7.93e-05	0.00753	CbGpPWpGaD
Sparfloxacin—Alanine aminotransferase increased—Doxorubicin—kidney cancer	7.9e-05	0.000395	CcSEcCtD
Sparfloxacin—Vomiting—Sunitinib—kidney cancer	7.87e-05	0.000394	CcSEcCtD
Sparfloxacin—Body temperature increased—Gemcitabine—kidney cancer	7.86e-05	0.000393	CcSEcCtD
Sparfloxacin—Tremor—Capecitabine—kidney cancer	7.84e-05	0.000392	CcSEcCtD
Sparfloxacin—Rash—Sunitinib—kidney cancer	7.81e-05	0.000391	CcSEcCtD
Sparfloxacin—Dermatitis—Sunitinib—kidney cancer	7.8e-05	0.000391	CcSEcCtD
Sparfloxacin—Ill-defined disorder—Capecitabine—kidney cancer	7.76e-05	0.000389	CcSEcCtD
Sparfloxacin—Headache—Sunitinib—kidney cancer	7.76e-05	0.000389	CcSEcCtD
Sparfloxacin—Asthma—Doxorubicin—kidney cancer	7.74e-05	0.000388	CcSEcCtD
Sparfloxacin—Hypersensitivity—Vincristine—kidney cancer	7.72e-05	0.000386	CcSEcCtD
Sparfloxacin—Nausea—Sorafenib—kidney cancer	7.65e-05	0.000383	CcSEcCtD
Sparfloxacin—Pancreatitis—Doxorubicin—kidney cancer	7.59e-05	0.00038	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	7.58e-05	0.00038	CcSEcCtD
Sparfloxacin—Malaise—Capecitabine—kidney cancer	7.54e-05	0.000378	CcSEcCtD
Sparfloxacin—Angina pectoris—Doxorubicin—kidney cancer	7.54e-05	0.000378	CcSEcCtD
Sparfloxacin—Insomnia—Paclitaxel—kidney cancer	7.53e-05	0.000377	CcSEcCtD
Sparfloxacin—Vertigo—Capecitabine—kidney cancer	7.52e-05	0.000376	CcSEcCtD
Sparfloxacin—Asthenia—Vincristine—kidney cancer	7.52e-05	0.000376	CcSEcCtD
Sparfloxacin—Paraesthesia—Paclitaxel—kidney cancer	7.47e-05	0.000374	CcSEcCtD
Sparfloxacin—Vomiting—Dactinomycin—kidney cancer	7.45e-05	0.000373	CcSEcCtD
Sparfloxacin—Bronchitis—Doxorubicin—kidney cancer	7.44e-05	0.000373	CcSEcCtD
Sparfloxacin—Dyspnoea—Paclitaxel—kidney cancer	7.42e-05	0.000371	CcSEcCtD
Sparfloxacin—Somnolence—Paclitaxel—kidney cancer	7.4e-05	0.00037	CcSEcCtD
Sparfloxacin—Palpitations—Capecitabine—kidney cancer	7.39e-05	0.00037	CcSEcCtD
Sparfloxacin—Rash—Dactinomycin—kidney cancer	7.39e-05	0.00037	CcSEcCtD
Sparfloxacin—Nausea—Sunitinib—kidney cancer	7.36e-05	0.000368	CcSEcCtD
Sparfloxacin—Pancytopenia—Doxorubicin—kidney cancer	7.35e-05	0.000368	CcSEcCtD
Sparfloxacin—Dyspepsia—Paclitaxel—kidney cancer	7.32e-05	0.000367	CcSEcCtD
Sparfloxacin—Cough—Capecitabine—kidney cancer	7.3e-05	0.000366	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	7.28e-05	0.00692	CbGpPWpGaD
Sparfloxacin—TOP2A—Gastric Cancer Network 2—TP53—kidney cancer	7.26e-05	0.00689	CbGpPWpGaD
Sparfloxacin—Dysuria—Doxorubicin—kidney cancer	7.24e-05	0.000362	CcSEcCtD
Sparfloxacin—Decreased appetite—Paclitaxel—kidney cancer	7.23e-05	0.000362	CcSEcCtD
Sparfloxacin—Hypertension—Capecitabine—kidney cancer	7.22e-05	0.000362	CcSEcCtD
Sparfloxacin—Diarrhoea—Vincristine—kidney cancer	7.17e-05	0.000359	CcSEcCtD
Sparfloxacin—Asthenia—Gemcitabine—kidney cancer	7.13e-05	0.000357	CcSEcCtD
Sparfloxacin—Arthralgia—Capecitabine—kidney cancer	7.12e-05	0.000357	CcSEcCtD
Sparfloxacin—Chest pain—Capecitabine—kidney cancer	7.12e-05	0.000357	CcSEcCtD
Sparfloxacin—Myalgia—Capecitabine—kidney cancer	7.12e-05	0.000357	CcSEcCtD
Sparfloxacin—Constipation—Paclitaxel—kidney cancer	7.11e-05	0.000356	CcSEcCtD
Sparfloxacin—Pain—Paclitaxel—kidney cancer	7.11e-05	0.000356	CcSEcCtD
Sparfloxacin—Anxiety—Capecitabine—kidney cancer	7.1e-05	0.000355	CcSEcCtD
Sparfloxacin—Photosensitivity reaction—Doxorubicin—kidney cancer	7.06e-05	0.000354	CcSEcCtD
Sparfloxacin—Discomfort—Capecitabine—kidney cancer	7.04e-05	0.000352	CcSEcCtD
Sparfloxacin—Pruritus—Gemcitabine—kidney cancer	7.03e-05	0.000352	CcSEcCtD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2B—kidney cancer	7.03e-05	0.00667	CbGpPWpGaD
Sparfloxacin—Dry mouth—Capecitabine—kidney cancer	6.97e-05	0.000349	CcSEcCtD
Sparfloxacin—Nausea—Dactinomycin—kidney cancer	6.96e-05	0.000349	CcSEcCtD
Sparfloxacin—Pneumonia—Doxorubicin—kidney cancer	6.94e-05	0.000348	CcSEcCtD
Sparfloxacin—Dizziness—Vincristine—kidney cancer	6.93e-05	0.000347	CcSEcCtD
Sparfloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—kidney cancer	6.9e-05	0.00655	CbGpPWpGaD
Sparfloxacin—Confusional state—Capecitabine—kidney cancer	6.88e-05	0.000345	CcSEcCtD
Sparfloxacin—Feeling abnormal—Paclitaxel—kidney cancer	6.86e-05	0.000343	CcSEcCtD
Sparfloxacin—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	6.84e-05	0.000343	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Paclitaxel—kidney cancer	6.8e-05	0.000341	CcSEcCtD
Sparfloxacin—Diarrhoea—Gemcitabine—kidney cancer	6.8e-05	0.00034	CcSEcCtD
Sparfloxacin—Stomatitis—Doxorubicin—kidney cancer	6.73e-05	0.000337	CcSEcCtD
Sparfloxacin—Jaundice—Doxorubicin—kidney cancer	6.73e-05	0.000337	CcSEcCtD
Sparfloxacin—Conjunctivitis—Doxorubicin—kidney cancer	6.71e-05	0.000336	CcSEcCtD
Sparfloxacin—Urinary tract infection—Doxorubicin—kidney cancer	6.71e-05	0.000336	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Capecitabine—kidney cancer	6.69e-05	0.000335	CcSEcCtD
Sparfloxacin—Tachycardia—Capecitabine—kidney cancer	6.66e-05	0.000334	CcSEcCtD
Sparfloxacin—Vomiting—Vincristine—kidney cancer	6.66e-05	0.000334	CcSEcCtD
Sparfloxacin—Sweating—Doxorubicin—kidney cancer	6.62e-05	0.000331	CcSEcCtD
Sparfloxacin—Urticaria—Paclitaxel—kidney cancer	6.61e-05	0.000331	CcSEcCtD
Sparfloxacin—Rash—Vincristine—kidney cancer	6.6e-05	0.000331	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Capecitabine—kidney cancer	6.6e-05	0.000331	CcSEcCtD
Sparfloxacin—Dermatitis—Vincristine—kidney cancer	6.6e-05	0.00033	CcSEcCtD
Sparfloxacin—Haematuria—Doxorubicin—kidney cancer	6.58e-05	0.000329	CcSEcCtD
Sparfloxacin—Body temperature increased—Paclitaxel—kidney cancer	6.58e-05	0.000329	CcSEcCtD
Sparfloxacin—Abdominal pain—Paclitaxel—kidney cancer	6.58e-05	0.000329	CcSEcCtD
Sparfloxacin—Headache—Vincristine—kidney cancer	6.56e-05	0.000329	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	6.54e-05	0.00621	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	6.54e-05	0.00621	CbGpPWpGaD
Sparfloxacin—Epistaxis—Doxorubicin—kidney cancer	6.51e-05	0.000326	CcSEcCtD
Sparfloxacin—Anorexia—Capecitabine—kidney cancer	6.51e-05	0.000326	CcSEcCtD
Sparfloxacin—Sinusitis—Doxorubicin—kidney cancer	6.47e-05	0.000324	CcSEcCtD
Sparfloxacin—Agranulocytosis—Doxorubicin—kidney cancer	6.44e-05	0.000322	CcSEcCtD
Sparfloxacin—Vomiting—Gemcitabine—kidney cancer	6.32e-05	0.000316	CcSEcCtD
Sparfloxacin—Rash—Gemcitabine—kidney cancer	6.27e-05	0.000314	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—RYR1—kidney cancer	6.26e-05	0.00595	CbGpPWpGaD
Sparfloxacin—Dermatitis—Gemcitabine—kidney cancer	6.26e-05	0.000313	CcSEcCtD
Sparfloxacin—Haemoglobin—Doxorubicin—kidney cancer	6.23e-05	0.000312	CcSEcCtD
Sparfloxacin—Headache—Gemcitabine—kidney cancer	6.23e-05	0.000312	CcSEcCtD
Sparfloxacin—Nausea—Vincristine—kidney cancer	6.22e-05	0.000312	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Capecitabine—kidney cancer	6.22e-05	0.000311	CcSEcCtD
Sparfloxacin—Rhinitis—Doxorubicin—kidney cancer	6.21e-05	0.000311	CcSEcCtD
Sparfloxacin—Haemorrhage—Doxorubicin—kidney cancer	6.19e-05	0.00031	CcSEcCtD
Sparfloxacin—Hepatitis—Doxorubicin—kidney cancer	6.19e-05	0.00031	CcSEcCtD
Sparfloxacin—Insomnia—Capecitabine—kidney cancer	6.18e-05	0.000309	CcSEcCtD
Sparfloxacin—Hypoaesthesia—Doxorubicin—kidney cancer	6.16e-05	0.000309	CcSEcCtD
Sparfloxacin—Pharyngitis—Doxorubicin—kidney cancer	6.15e-05	0.000308	CcSEcCtD
Sparfloxacin—Paraesthesia—Capecitabine—kidney cancer	6.13e-05	0.000307	CcSEcCtD
Sparfloxacin—Hypersensitivity—Paclitaxel—kidney cancer	6.13e-05	0.000307	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	6.12e-05	0.00581	CbGpPWpGaD
Sparfloxacin—Oedema peripheral—Doxorubicin—kidney cancer	6.1e-05	0.000306	CcSEcCtD
Sparfloxacin—Dyspnoea—Capecitabine—kidney cancer	6.09e-05	0.000305	CcSEcCtD
Sparfloxacin—Dyspepsia—Capecitabine—kidney cancer	6.01e-05	0.000301	CcSEcCtD
Sparfloxacin—Asthenia—Paclitaxel—kidney cancer	5.97e-05	0.000299	CcSEcCtD
Sparfloxacin—Decreased appetite—Capecitabine—kidney cancer	5.94e-05	0.000297	CcSEcCtD
Sparfloxacin—ABCC2—NRF2 pathway—SLC5A5—kidney cancer	5.92e-05	0.00562	CbGpPWpGaD
Sparfloxacin—Nausea—Gemcitabine—kidney cancer	5.9e-05	0.000296	CcSEcCtD
Sparfloxacin—Pruritus—Paclitaxel—kidney cancer	5.89e-05	0.000295	CcSEcCtD
Sparfloxacin—TOP2A—Circadian rythm related genes—EGR1—kidney cancer	5.87e-05	0.00558	CbGpPWpGaD
Sparfloxacin—Erythema multiforme—Doxorubicin—kidney cancer	5.86e-05	0.000293	CcSEcCtD
Sparfloxacin—Pain—Capecitabine—kidney cancer	5.84e-05	0.000292	CcSEcCtD
Sparfloxacin—Constipation—Capecitabine—kidney cancer	5.84e-05	0.000292	CcSEcCtD
Sparfloxacin—Tinnitus—Doxorubicin—kidney cancer	5.78e-05	0.000289	CcSEcCtD
Sparfloxacin—ABCC2—NRF2 pathway—SLC2A1—kidney cancer	5.72e-05	0.00543	CbGpPWpGaD
Sparfloxacin—Diarrhoea—Paclitaxel—kidney cancer	5.69e-05	0.000285	CcSEcCtD
Sparfloxacin—Feeling abnormal—Capecitabine—kidney cancer	5.63e-05	0.000282	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Capecitabine—kidney cancer	5.58e-05	0.00028	CcSEcCtD
Sparfloxacin—Chills—Doxorubicin—kidney cancer	5.56e-05	0.000278	CcSEcCtD
Sparfloxacin—Arrhythmia—Doxorubicin—kidney cancer	5.53e-05	0.000277	CcSEcCtD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RAF1—kidney cancer	5.52e-05	0.00524	CbGpPWpGaD
Sparfloxacin—Dizziness—Paclitaxel—kidney cancer	5.5e-05	0.000276	CcSEcCtD
Sparfloxacin—Alopecia—Doxorubicin—kidney cancer	5.47e-05	0.000274	CcSEcCtD
Sparfloxacin—Urticaria—Capecitabine—kidney cancer	5.42e-05	0.000272	CcSEcCtD
Sparfloxacin—Body temperature increased—Capecitabine—kidney cancer	5.4e-05	0.00027	CcSEcCtD
Sparfloxacin—Abdominal pain—Capecitabine—kidney cancer	5.4e-05	0.00027	CcSEcCtD
Sparfloxacin—ABCB1—Allograft Rejection—IL13—kidney cancer	5.39e-05	0.00511	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	5.37e-05	0.0051	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	5.32e-05	0.00506	CbGpPWpGaD
Sparfloxacin—Flatulence—Doxorubicin—kidney cancer	5.31e-05	0.000266	CcSEcCtD
Sparfloxacin—ABCC2—NRF2 pathway—EGR1—kidney cancer	5.31e-05	0.00504	CbGpPWpGaD
Sparfloxacin—Tension—Doxorubicin—kidney cancer	5.29e-05	0.000265	CcSEcCtD
Sparfloxacin—Vomiting—Paclitaxel—kidney cancer	5.29e-05	0.000265	CcSEcCtD
Sparfloxacin—Dysgeusia—Doxorubicin—kidney cancer	5.28e-05	0.000264	CcSEcCtD
Sparfloxacin—Rash—Paclitaxel—kidney cancer	5.25e-05	0.000263	CcSEcCtD
Sparfloxacin—Dermatitis—Paclitaxel—kidney cancer	5.24e-05	0.000262	CcSEcCtD
Sparfloxacin—Nervousness—Doxorubicin—kidney cancer	5.24e-05	0.000262	CcSEcCtD
Sparfloxacin—Back pain—Doxorubicin—kidney cancer	5.22e-05	0.000261	CcSEcCtD
Sparfloxacin—Headache—Paclitaxel—kidney cancer	5.21e-05	0.000261	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	5.2e-05	0.00494	CbGpPWpGaD
Sparfloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	5.11e-05	0.00485	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—kidney cancer	5.08e-05	0.00482	CbGpPWpGaD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—kidney cancer	5.06e-05	0.0048	CbGpPWpGaD
Sparfloxacin—Hypersensitivity—Capecitabine—kidney cancer	5.03e-05	0.000252	CcSEcCtD
Sparfloxacin—Ill-defined disorder—Doxorubicin—kidney cancer	5e-05	0.000251	CcSEcCtD
Sparfloxacin—Agitation—Doxorubicin—kidney cancer	4.96e-05	0.000248	CcSEcCtD
Sparfloxacin—Nausea—Paclitaxel—kidney cancer	4.94e-05	0.000247	CcSEcCtD
Sparfloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	4.93e-05	0.00468	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—ANXA2—kidney cancer	4.92e-05	0.00467	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—ATP7B—kidney cancer	4.92e-05	0.00467	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC5A3—kidney cancer	4.92e-05	0.00467	CbGpPWpGaD
Sparfloxacin—Asthenia—Capecitabine—kidney cancer	4.9e-05	0.000245	CcSEcCtD
Sparfloxacin—Malaise—Doxorubicin—kidney cancer	4.86e-05	0.000244	CcSEcCtD
Sparfloxacin—Vertigo—Doxorubicin—kidney cancer	4.85e-05	0.000243	CcSEcCtD
Sparfloxacin—Pruritus—Capecitabine—kidney cancer	4.83e-05	0.000242	CcSEcCtD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—kidney cancer	4.82e-05	0.00458	CbGpPWpGaD
Sparfloxacin—ABCC2—NRF2 pathway—GSTP1—kidney cancer	4.77e-05	0.00453	CbGpPWpGaD
Sparfloxacin—Palpitations—Doxorubicin—kidney cancer	4.77e-05	0.000239	CcSEcCtD
Sparfloxacin—Cough—Doxorubicin—kidney cancer	4.71e-05	0.000236	CcSEcCtD
Sparfloxacin—Convulsion—Doxorubicin—kidney cancer	4.67e-05	0.000234	CcSEcCtD
Sparfloxacin—Diarrhoea—Capecitabine—kidney cancer	4.67e-05	0.000234	CcSEcCtD
Sparfloxacin—Hypertension—Doxorubicin—kidney cancer	4.66e-05	0.000233	CcSEcCtD
Sparfloxacin—Arthralgia—Doxorubicin—kidney cancer	4.59e-05	0.00023	CcSEcCtD
Sparfloxacin—Myalgia—Doxorubicin—kidney cancer	4.59e-05	0.00023	CcSEcCtD
Sparfloxacin—Chest pain—Doxorubicin—kidney cancer	4.59e-05	0.00023	CcSEcCtD
Sparfloxacin—Anxiety—Doxorubicin—kidney cancer	4.58e-05	0.000229	CcSEcCtD
Sparfloxacin—Discomfort—Doxorubicin—kidney cancer	4.54e-05	0.000227	CcSEcCtD
Sparfloxacin—Dizziness—Capecitabine—kidney cancer	4.52e-05	0.000226	CcSEcCtD
Sparfloxacin—Dry mouth—Doxorubicin—kidney cancer	4.49e-05	0.000225	CcSEcCtD
Sparfloxacin—Confusional state—Doxorubicin—kidney cancer	4.44e-05	0.000222	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Doxorubicin—kidney cancer	4.4e-05	0.00022	CcSEcCtD
Sparfloxacin—ABCC2—NRF2 pathway—GSTM1—kidney cancer	4.38e-05	0.00416	CbGpPWpGaD
Sparfloxacin—Vomiting—Capecitabine—kidney cancer	4.34e-05	0.000217	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Doxorubicin—kidney cancer	4.31e-05	0.000216	CcSEcCtD
Sparfloxacin—Rash—Capecitabine—kidney cancer	4.31e-05	0.000216	CcSEcCtD
Sparfloxacin—Dermatitis—Capecitabine—kidney cancer	4.3e-05	0.000215	CcSEcCtD
Sparfloxacin—Tachycardia—Doxorubicin—kidney cancer	4.3e-05	0.000215	CcSEcCtD
Sparfloxacin—Headache—Capecitabine—kidney cancer	4.28e-05	0.000214	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Doxorubicin—kidney cancer	4.25e-05	0.000213	CcSEcCtD
Sparfloxacin—Anorexia—Doxorubicin—kidney cancer	4.2e-05	0.00021	CcSEcCtD
Sparfloxacin—Nausea—Capecitabine—kidney cancer	4.06e-05	0.000203	CcSEcCtD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—kidney cancer	4.02e-05	0.00382	CbGpPWpGaD
Sparfloxacin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	4.01e-05	0.000201	CcSEcCtD
Sparfloxacin—Insomnia—Doxorubicin—kidney cancer	3.98e-05	0.000199	CcSEcCtD
Sparfloxacin—Paraesthesia—Doxorubicin—kidney cancer	3.95e-05	0.000198	CcSEcCtD
Sparfloxacin—Dyspnoea—Doxorubicin—kidney cancer	3.92e-05	0.000196	CcSEcCtD
Sparfloxacin—Somnolence—Doxorubicin—kidney cancer	3.91e-05	0.000196	CcSEcCtD
Sparfloxacin—Dyspepsia—Doxorubicin—kidney cancer	3.87e-05	0.000194	CcSEcCtD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—kidney cancer	3.87e-05	0.00368	CbGpPWpGaD
Sparfloxacin—Decreased appetite—Doxorubicin—kidney cancer	3.83e-05	0.000192	CcSEcCtD
Sparfloxacin—Constipation—Doxorubicin—kidney cancer	3.76e-05	0.000188	CcSEcCtD
Sparfloxacin—Pain—Doxorubicin—kidney cancer	3.76e-05	0.000188	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	3.75e-05	0.00356	CbGpPWpGaD
Sparfloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—kidney cancer	3.67e-05	0.00348	CbGpPWpGaD
Sparfloxacin—Feeling abnormal—Doxorubicin—kidney cancer	3.63e-05	0.000182	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Doxorubicin—kidney cancer	3.6e-05	0.00018	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—ATP7B—kidney cancer	3.6e-05	0.00342	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SLC5A3—kidney cancer	3.6e-05	0.00342	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—ANXA2—kidney cancer	3.6e-05	0.00342	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—kidney cancer	3.56e-05	0.00338	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—PSMD7—kidney cancer	3.53e-05	0.00335	CbGpPWpGaD
Sparfloxacin—Urticaria—Doxorubicin—kidney cancer	3.5e-05	0.000175	CcSEcCtD
Sparfloxacin—Abdominal pain—Doxorubicin—kidney cancer	3.48e-05	0.000174	CcSEcCtD
Sparfloxacin—Body temperature increased—Doxorubicin—kidney cancer	3.48e-05	0.000174	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—AURKA—kidney cancer	3.43e-05	0.00326	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—kidney cancer	3.39e-05	0.00322	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—HIF1A—kidney cancer	3.28e-05	0.00311	CbGpPWpGaD
Sparfloxacin—Hypersensitivity—Doxorubicin—kidney cancer	3.24e-05	0.000162	CcSEcCtD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—kidney cancer	3.18e-05	0.00302	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—JUND—kidney cancer	3.17e-05	0.00301	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—APAF1—kidney cancer	3.17e-05	0.00301	CbGpPWpGaD
Sparfloxacin—Asthenia—Doxorubicin—kidney cancer	3.16e-05	0.000158	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—PSMD7—kidney cancer	3.15e-05	0.00299	CbGpPWpGaD
Sparfloxacin—Pruritus—Doxorubicin—kidney cancer	3.11e-05	0.000156	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—AURKA—kidney cancer	3.07e-05	0.00291	CbGpPWpGaD
Sparfloxacin—Diarrhoea—Doxorubicin—kidney cancer	3.01e-05	0.000151	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	3e-05	0.00285	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—RYR1—kidney cancer	2.94e-05	0.0028	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	2.94e-05	0.00279	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	2.91e-05	0.00276	CbGpPWpGaD
Sparfloxacin—Dizziness—Doxorubicin—kidney cancer	2.91e-05	0.000146	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	2.85e-05	0.0027	CbGpPWpGaD
Sparfloxacin—Vomiting—Doxorubicin—kidney cancer	2.8e-05	0.00014	CcSEcCtD
Sparfloxacin—Rash—Doxorubicin—kidney cancer	2.78e-05	0.000139	CcSEcCtD
Sparfloxacin—Dermatitis—Doxorubicin—kidney cancer	2.77e-05	0.000139	CcSEcCtD
Sparfloxacin—Headache—Doxorubicin—kidney cancer	2.76e-05	0.000138	CcSEcCtD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—kidney cancer	2.72e-05	0.00259	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	2.7e-05	0.00256	CbGpPWpGaD
Sparfloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—kidney cancer	2.64e-05	0.0025	CbGpPWpGaD
Sparfloxacin—Nausea—Doxorubicin—kidney cancer	2.61e-05	0.000131	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	2.61e-05	0.00248	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.59e-05	0.00246	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2B—kidney cancer	2.58e-05	0.00245	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	2.57e-05	0.00244	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	2.57e-05	0.00244	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	2.55e-05	0.00242	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.51e-05	0.00238	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	2.48e-05	0.00236	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—JUN—kidney cancer	2.46e-05	0.00234	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	2.4e-05	0.00228	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—PTEN—kidney cancer	2.38e-05	0.00226	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—BRCA2—kidney cancer	2.32e-05	0.00221	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CDKN2B—kidney cancer	2.3e-05	0.00219	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	2.24e-05	0.00213	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—BIRC5—kidney cancer	2.22e-05	0.00211	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	2.15e-05	0.00204	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	2.15e-05	0.00204	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	2.12e-05	0.00201	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	2.06e-05	0.00196	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	2.02e-05	0.00192	CbGpPWpGaD
Sparfloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—kidney cancer	2.02e-05	0.00192	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	2.01e-05	0.00191	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—BIRC5—kidney cancer	1.99e-05	0.00189	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.98e-05	0.00188	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—JUN—kidney cancer	1.98e-05	0.00188	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.91e-05	0.00181	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.9e-05	0.0018	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.83e-05	0.00174	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	1.77e-05	0.00168	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—IL2—kidney cancer	1.76e-05	0.00167	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	1.75e-05	0.00166	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.75e-05	0.00166	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—kidney cancer	1.73e-05	0.00164	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.69e-05	0.00161	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	1.69e-05	0.00161	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ATP7B—kidney cancer	1.69e-05	0.00161	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ANXA2—kidney cancer	1.69e-05	0.00161	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—TP53—kidney cancer	1.63e-05	0.00154	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ACY1—kidney cancer	1.51e-05	0.00143	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—VEGFA—kidney cancer	1.5e-05	0.00142	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—kidney cancer	1.47e-05	0.0014	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.45e-05	0.00137	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CDKN2A—kidney cancer	1.32e-05	0.00125	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—kidney cancer	1.31e-05	0.00124	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PDHB—kidney cancer	1.28e-05	0.00122	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—kidney cancer	1.25e-05	0.00118	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	1.23e-05	0.00117	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CCBL1—kidney cancer	1.21e-05	0.00114	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CDKN1B—kidney cancer	1.17e-05	0.00111	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—RAF1—kidney cancer	1.12e-05	0.00106	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CCND1—kidney cancer	1.11e-05	0.00106	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PPAT—kidney cancer	1.05e-05	0.000992	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GLIPR1—kidney cancer	1.05e-05	0.000992	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—kidney cancer	1.03e-05	0.000975	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—MYC—kidney cancer	9.99e-06	0.000948	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—MAPK1—kidney cancer	9.77e-06	0.000928	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—APRT—kidney cancer	9.72e-06	0.000923	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—FH—kidney cancer	9.72e-06	0.000923	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	9.69e-06	0.00092	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	9.59e-06	0.00091	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	9.37e-06	0.00089	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—MAPK3—kidney cancer	9.18e-06	0.000872	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GPC3—kidney cancer	9.13e-06	0.000867	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—MYC—kidney cancer	8.93e-06	0.000848	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	8.92e-06	0.000847	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CA2—kidney cancer	8.89e-06	0.000844	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	8.88e-06	0.000843	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—MAPK1—kidney cancer	8.74e-06	0.00083	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ALAD—kidney cancer	8.66e-06	0.000822	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	8.61e-06	0.000818	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	8.47e-06	0.000804	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ST3GAL2—kidney cancer	8.45e-06	0.000803	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	8.45e-06	0.000803	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	8.39e-06	0.000796	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ALDH1A1—kidney cancer	8.26e-06	0.000784	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—RAF1—kidney cancer	8.18e-06	0.000777	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	8.17e-06	0.000776	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PGK1—kidney cancer	7.92e-06	0.000752	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SLC5A3—kidney cancer	7.92e-06	0.000752	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—LDHB—kidney cancer	7.77e-06	0.000738	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	7.38e-06	0.000701	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—TP53—kidney cancer	7.33e-06	0.000696	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	6.98e-06	0.000663	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	6.79e-06	0.000645	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CA9—kidney cancer	6.73e-06	0.000639	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	6.65e-06	0.000631	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	6.28e-06	0.000596	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	5.77e-06	0.000548	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CRABP1—kidney cancer	5.73e-06	0.000544	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	5.58e-06	0.00053	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ITPR2—kidney cancer	5.32e-06	0.000505	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTT1—kidney cancer	4.85e-06	0.000461	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ACHE—kidney cancer	4.85e-06	0.000461	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SCARB1—kidney cancer	4.59e-06	0.000436	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PTGS1—kidney cancer	4.55e-06	0.000432	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PSMD7—kidney cancer	4.46e-06	0.000424	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—BCHE—kidney cancer	4.23e-06	0.000402	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SLC5A5—kidney cancer	4.18e-06	0.000397	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SLC2A1—kidney cancer	4.03e-06	0.000383	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	3.85e-06	0.000365	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTP1—kidney cancer	3.36e-06	0.00032	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTM1—kidney cancer	3.09e-06	0.000294	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CYP1A1—kidney cancer	2.93e-06	0.000278	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—POMC—kidney cancer	2.19e-06	0.000208	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PTGS2—kidney cancer	1.74e-06	0.000166	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PTEN—kidney cancer	1.52e-06	0.000144	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PIK3CA—kidney cancer	1.07e-06	0.000102	CbGpPWpGaD
